Last reviewed · How we verify

NCT06845371

MELODY Registry Follow-Up Study

Not yet recruiting Last updated 25 February 2025
What this trial tests

trial in Congenital Heart Disease (CHD) in 845 participants. Not yet recruiting.

Timeline
1 May 2025
Primary endpoint
1 May 2027
1 August 2027

Quick facts

Lead sponsorUniversity Hospital Tuebingen
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment845
Start date1 May 2025
Primary completion1 May 2027
Estimated completion1 August 2027

Conditions studied

Sponsor

University Hospital Tuebingen

Who can join

Eligibility, any sex, with Congenital Heart Disease (CHD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Extension of the MELODY Registry, to assess longterm follow-up clinical results of Melody valve implantation after its commercialization in Europe / OUS

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Congenital Heart Disease (CHD)

Currently open trials in the same condition.

Other University Hospital Tuebingen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06845371.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing